Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

34.42
0.0000
Volume:7
Turnover:240.22
Market Cap:13.77M
PE:- -
High:34.42
Open:34.42
Low:34.42
Close:34.42
52wk High:34.86
52wk Low:25.79
Shares:400.00K
Float Shares:400.00K
Volume Ratio:0.33
T/O Rate:0.00%
Dividend:0.08
Dividend Rate:0.24%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

SR Medical Jumps Over 5% in Morning Trade, Pivoting to AI-Driven Digital Healthcare

Deep News
·
Aug 26

Unified Pathology Index Launches Nationwide, One Code Bridges Data Gaps for Precision Care

Stock News
·
Aug 26

Rhythm Biosciences strengthens board to support global cancer diagnostics push

TIPRANKS
·
Aug 26

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 26

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 26

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 26

Merck & Co. Inc. Stock Rises 3.8%, Outperforms Peers

Dow Jones
·
Aug 26

Moderna Inc. Stock Rallies 14.4%, Outperforms Peers

Dow Jones
·
Aug 26

Dow up 136 Points on Gains for Shares of Merck, Goldman Sachs

Dow Jones
·
Aug 26

Merck & Co Inc Stock (MRK) Moved Up by 3.76% on Aug 25: A Full Analysis

TradingKey
·
Aug 26

Moderna Stock (MRNA) Rises 12.5% Today Following Phase 3 mRNA Cancer Vaccine Win with Merck

TIPRANKS
·
Aug 26

BeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA

TIPRANKS
·
Aug 25

U.S. FDA Approves Ziihera® (zanidatamab-hrii) with and without Tislelizumab plus Chemotherapy in First-Line HER2+ Advanced Gastroesophageal Adenocarcinoma

GlobeNewswire
·
Aug 25

Moderna Inc Stock (MRNA) Moved Up by 10.02% on Aug 25: Drivers Behind the Movement

TradingKey
·
Aug 25

Sector Update: Healthcare Stocks Edge Higher Premarket Tuesday

MT Newswires Live
·
Aug 25

Merck Price Target Raised to $170.00/Share from $145.00 by Argus Research

Dow Jones
·
Aug 25

Endurance RP lifts profit on China milestone as telehealth and Fortacin™ expansion advance

TIPRANKS
·
Aug 25

Merck & Company (MRK) Gets a Buy from Scotiabank

TIPRANKS
·
Aug 25

Merck price target raised to $170 from $145 at Argus

TIPRANKS
·
Aug 25

Veeva Systems Secures Biogen, Regeneron Pharmaceuticals as New Vault CRM Clients

MT Newswires Live
·
Aug 25